Form 4: Director Kathleen Gilmartin Acquires US Physical Therapy Stock

Sentiment:

Insider Transaction Report


Director Kathleen Gilmartin acquired 2,306 shares of U.S. Physical Therapy Inc. common stock on May 19, 2026, as part of a restricted stock grant.

Summary

  • Kathleen Gilmartin, a Director at U.S. Physical Therapy Inc. (USPH), acquired 2,306 shares of common stock on May 19, 2026.
  • The acquisition was made under the Company's Amended and Restated 2003 Stock Incentive Plan and was valued at $61.61 per share.
  • These shares were granted as restricted stock, with restrictions lapsing on specific dates in 2026 and 2027, contingent on her continued directorship.
  • Following this transaction, Gilmartin beneficially owns 27,092 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider stock grant and acquisition rather than a significant new development or financial event.

Positives

  • Director acquisition of company stock can signal confidence in the company's future prospects.
  • The restricted stock grant indicates a long-term incentive structure for management and directors.
  • The acquisition was made at a specific price, providing transparency on valuation at the time of the grant.

Negatives

  • The shares are restricted, meaning they cannot be fully traded until certain dates in the future.
  • The vesting of the restricted stock is contingent on continued directorship, which introduces a potential risk of forfeiture if the director's tenure ends prematurely.

Risks

  • The restricted stock is subject to forfeiture if the director is not in office on the specified vesting dates.
  • Potential for future sales of vested shares could impact stock price if not managed strategically.

Future Outlook

The filing details the vesting schedule for restricted stock granted to Director Kathleen Gilmartin, with portions vesting in August 2026, November 2026, and March 2027, contingent on her continued directorship.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly restricted stock grants, are common in the healthcare services sector as a means to align management and director interests with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The acquisition by a director may be viewed positively as a sign of confidence, but the restricted nature of the shares limits immediate market impact.
  • Employees: The incentive plan structure may indirectly influence employee morale and retention if they are aware of similar compensation practices.
  • Management: Reinforces the alignment of director incentives with long-term company performance.

Next Steps

  • Monitoring the vesting of restricted shares on August 20, 2026, November 20, 2026, and March 6, 2027.
  • Observing any future transactions by Director Gilmartin upon vesting of these shares.

Key Dates

DateDescription
05/19/2026Transaction Date for stock acquisition.
08/20/2026Vesting date for 1,153 restricted shares.
11/20/2026Vesting date for 576 restricted shares.
03/06/2027Vesting date for 577 restricted shares.

Keywords

US Physical Therapy, USPH, Form 4, Insider Trading, Stock Acquisition, Restricted Stock, Director Compensation, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.